1. Home
  2. Proportional hazards model
  Subject:

Proportional hazards model   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
RELATED SUBJECTS:
The publications listed also have these subjects
Confidence interval  9 times
Breast cancer  6 times
Kaplan–Meier estimator  4 times
Estrogen receptor  4 times
Diabetes mellitus type 2  4 times
Cardiovascular disease  4 times
Univariate  3 times
Multivariate analysis  3 times
Metastasis  3 times
Logistic regression  3 times
Diabetes mellitus  3 times
Chronic kidney disease  3 times
Chemotherapy  3 times
Smoking cessation  2 times
Rheumatoid arthritis  2 times
Renal function  2 times
Regression analysis  2 times
Radiation therapy  2 times
Protein  2 times
Prostatectomy  2 times
Prostate cancer  2 times
Prostate  2 times
Progression-free survival  2 times
Ovarian cancer  2 times
Obesity  2 times
Neoadjuvant therapy  2 times
Lymph node  2 times
Hormone  2 times
Hong Kong  2 times
Hepatitis B  2 times
Hazard  2 times
Glioma  2 times
Glioblastoma multiforme  2 times
Finnish language  2 times
DNA methylation  2 times
Cumulative incidence  2 times
Creatinine  2 times
Carcinoma  2 times
Body mass index  2 times
Biomarker  2 times
Adjuvant  2 times
World Health Organization  1 time
Viral hepatitis  1 time
Univariate analysis  1 time
United States Census  1 time
Tumor necrosis factor superfamily  1 time
Tumor necrosis factor alpha  1 time
Troponin  1 time
Tocilizumab  1 time
Thyroid hormones  1 time
The Cancer Genome Atlas  1 time
Testosterone  1 time
Test cricket  1 time
Telomerase reverse transcriptase  1 time
Teaching hospital  1 time
TNM staging system  1 time
Survival analysis  1 time
Subgroup analysis  1 time
Statistical power  1 time
Sepsis  1 time
Sensitivity analysis  1 time
Selection bias  1 time
Rituximab  1 time
Retinal detachment  1 time
Questionnaire  1 time
Quantile  1 time
Pulse wave velocity  1 time
Psoriatic arthritis  1 time
Progesterone receptor  1 time
Prime Time Entertainment Network  1 time
Pre-eclampsia  1 time
Periodontitis  1 time
Osteoporosis  1 time
Osteoarthritis  1 time
Non-alcoholic fatty liver disease  1 time
Neutrophil  1 time
Neu!  1 time
Natriuretic peptide  1 time
N-terminal prohormone of brain natriuretic peptide  1 time
Myeloid tissue  1 time
Munhwa Broadcasting Corporation  1 time
Multiple myeloma  1 time
Molecular biology  1 time
Mixed model  1 time
Millennium Development Goals  1 time
Metabolism  1 time
Medicaid  1 time
Mayo Clinic  1 time
Maximum likelihood estimation  1 time
Mastectomy  1 time
MLH1  1 time
Lymphadenopathy  1 time
Lung cancer  1 time
Log-rank test  1 time
Lipoprotein  1 time
Lenalidomide  1 time
Kidney transplantation  1 time
Japan  1 time
Inverse probability  1 time
Interquartile range  1 time
Intensive care unit  1 time
Inguinal hernia  1 time
Infliximab  1 time
Inflammatory bowel disease  1 time
Infarction  1 time
Immunohistochemistry  1 time
Illumina dye sequencing  1 time
Hysterectomy  1 time
Histology  1 time
Hispanic and Latino Americans  1 time
Hepatocellular carcinoma  1 time
Hepatitis C virus  1 time
Helicobacter pylori  1 time
Heart failure  1 time
HIV  1 time
Gout  1 time
Glaucoma  1 time
Gestational diabetes  1 time
Gene  1 time
Fluorescence  1 time
Flat spline  1 time
Finland  1 time
Etanercept  1 time
Estradiol  1 time
Estonian language  1 time
Enzyme inhibitor  1 time
Endothelium  1 time
Endometriosis  1 time
Endometrial cancer  1 time
Embryo transfer  1 time
Disease-modifying antirheumatic drug  1 time
Disease  1 time
Dialysis  1 time
Diabetic retinopathy  1 time
Deconvolution  1 time
DNA  1 time
Cytopathology  1 time
Curve fitting  1 time
CpG site  1 time
Corticosteroid  1 time
Coronary artery disease  1 time
Common carotid artery  1 time
Colorectal cancer  1 time
Colitis  1 time
Colectomy  1 time
Colchicine  1 time
Cirrhosis  1 time
Cholesterol  1 time
Central nervous system  1 time
Cascading Style Sheets  1 time
CA-125  1 time
Bortezomib  1 time
Blood plasma  1 time
Bladder cancer  1 time
Black people  1 time
Bisphosphonate  1 time
Biology  1 time
Bangladesh  1 time
Australia  1 time
Astrocytoma  1 time
Assisted reproductive technology  1 time
Arthroplasty  1 time
Antioxidant  1 time
Angiotensin-converting enzyme  1 time
Angiotensin  1 time
Anemia  1 time
American Joint Committee on Cancer  1 time
Allotransplantation  1 time
Algorithm  1 time
Alendronic acid  1 time
Albumin  1 time
Alberta  1 time
Adjuvant therapy  1 time
Adenocarcinoma  1 time
Adalimumab  1 time
Acute kidney injury  1 time
Acrylamide  1 time
Acid  1 time
Abatacept  1 time

Publications tagged with this subject: 46

Note: Top 50 publications shown only. Open an item panel to view more info


1. Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study

2. Gestational diabetes mellitus is a significant risk factor for long-term ophthalmic morbidity

3. Risk factors of flare in rheumatoid arthritis patients with both clinical and ultrasonographic remission: a retrospective study from China

4. A comprehensive analysis on child mortality and its determinants in Bangladesh using frailty models

5. Tooth loss and liver cancer incidence in a Finnish cohort

6. Influence of incidental radiation dose in the subventricular zone on survival in patients with glioblastoma multiforme treated with surgery, radiotherapy, and temozolomide

7. Short-term outcome after total hip arthroplasty using dual-mobility cup: report from Lithuanian Arthroplasty Register

8. Discrete survival model analysis of a couple’s smoking pattern and outcomes of assisted reproduction

9. Anticipatory Positive Urine Tests for Bladder Cancer

10. Prognostic value of alcohol consumption and some other dietary habits for survival in a cohort of Chinese men with lung cancer

11. Long-term outcomes and predictors of failure after surgery for stage IV apical pelvic organ prolapse

12. Synchronous endometrial and ovarian carcinomas: predictors of risk and associations with survival and tumor expression profiles

13. Smoking-related general and cause-specific mortality in Estonia

14. Prognostic significance of supradiaphragmatic lymph nodes at initial presentation in patients with stage III high-grade serous ovarian cancer

15. Healthy lifestyle impact on breast cancer-specific and all-cause mortality

16. Influence of clinical, societal, and treatment variables on racial differences in ER−/PR− breast cancer survival

17. Coronary heart disease incidence and mortality, and all-cause mortality among diabetic and non-diabetic people according to their smoking behavior in Finland

18. Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes

19. Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT

20. Causative factors for de novo inguinal hernia after robot-assisted radical prostatectomy

21. Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survival

22. Plasma trans-fatty acids levels and mortality: a cohort study based on 1999–2000 National Health and Nutrition Examination Survey (NHANES)

23. Incorporation of Treatment Response, Tumor Grade and Receptor Status Improves Staging Quality in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

24. TSH increment and the risk of incident type 2 diabetes mellitus in euthyroid subjects

25. Dietary total antioxidant capacity is inversely associated with all-cause and cardiovascular disease death of US adults

26. Comparable long-term oncologic outcomes of laparoscopic versus open pancreaticoduodenectomy for adenocarcinoma: a propensity score weighting analysis

27. Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post-metastatic survival: 35-year results from the Munich Cancer Registry

28. Negative lymph node count is an independent prognostic factor for patients with rectal cancer who received preoperative radiotherapy

29. Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study

30. Improved survival in Medicare patients with multiple myeloma: findings from a large nationwide and population-based cohort

31. Obesity in pediatric kidney transplant recipients and the risks of acute rejection, graft loss and death

32. Estrogen receptor quantitative measures and breast cancer survival

33. Treatment Persistence and Clinical Outcomes of Tumor Necrosis Factor Inhibitor Cycling or Switching to a New Mechanism of Action Therapy: Real-world Observational Study of Rheumatoid Arthritis Patients in the United States with Prior Tumor Necrosis F

34. Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk

35. Perceived racism and incident diabetes in the Black Women’s Health Study

36. Predictive factors on outcomes in metaplastic breast cancer

37. Association of baseline steroid use with long-term rates of infection and sepsis in the REGARDS cohort

38. Dietary acrylamide exposure was associated with increased cancer mortality in Chinese elderly men and women: a 11-year prospective study of Mr. and Ms. OS Hong Kong

39. Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes

40. UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression

41. Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry

42. Development of an Australian cardiovascular disease mortality risk score using multiple imputation and recalibration from national statistics

43. Pseudo maximum likelihood estimation for the Cox model with doubly truncated data

44. Prognostic value of platelet-to-lymphocyte ratios among critically ill patients with acute kidney injury

45. Incidence Rates and Predictors of Colectomy for Ulcerative Colitis in the Era of Biologics: Results from a Provincial Database

46. Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma


Questions?

Drop us a message.